Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. (Q46459616)
Jump to navigation
Jump to search
scientific article published in February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. |
scientific article published in February 2009 |
Statements
1 reference
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. (English)
1 reference
Paul J Kostenuik
1 reference
Hung Q Nguyen
1 reference
James McCabe
1 reference
Kelly S Warmington
1 reference
Carol Kurahara
1 reference
Ning Sun
1 reference
Ching Chen
1 reference
Luke Li
1 reference
Russ C Cattley
1 reference
Gwyneth Van
1 reference
Shelia Scully
1 reference
Robin Elliott
1 reference
Mario Grisanti
1 reference
Sean Morony
1 reference
Hong Lin Tan
1 reference
Frank Asuncion
1 reference
Xiaodong Li
1 reference
Michael S Ominsky
1 reference
Marina Stolina
1 reference
Denise Dwyer
1 reference
William C Dougall
1 reference
Nessa Hawkins
1 reference
William J Boyle
1 reference
William S Simonet
1 reference
John K Sullivan
1 reference
1 February 2009
1 reference
24
1 reference
182-195
1 reference
2
1 reference
Identifiers
1 reference
1 reference